CN Stock MarketDetailed Quotes

002275 Guilin Sanjin Pharmaceutical

Watchlist
  • 12.58
  • +0.05+0.40%
Market Closed Jul 12 15:00 CST
7.39BMarket Cap21.00P/E (TTM)

About Guilin Sanjin Pharmaceutical Company

The company is the core enterprise of the Sanjin Group. It is mainly engaged in the development and production of proprietary Chinese medicines and natural medicines, and is one of the earliest domestic manufacturers to produce modern traditional Chinese medicine preparations. Since 1985, Guilin Sanjin has insisted on reform and innovation. Relying on scientific progress and scientific management, it has transformed from an unknown small Chinese medicine workshop into a nationally renowned modern Chinese medicine enterprise, ranking among the top 50 Chinese medicine industry in China. The company's main business is R&D, manufacturing and sales of proprietary Chinese medicines. The main products are Sanjin Tablets, Guilin Watermelon Cream, Watermelon Cream Throat Tablets, Watermelon Cream Throat Cleanse Tablets, Cerebromatech Capsules, Dizziness Control Tablets/Granules, Jade Leaf Detox Granules, Lamotrigine Tablets (Comfort), Compound Tianqi Stomach Pain Capsules, etc. Corporate honors: The company has 42 exclusive specialty varieties and 52 invention patents (1 is an American invention patent, 1 is a national confidential invention patent, 4 invention patents have won the Chinese Patent Excellence Award, and is the only enterprise in Guangxi that has received the China Patent Excellence Award 4 times), 21 national traditional Chinese medicine protected varieties, and the innovative achievements have won 3 National Science and Technology Progress Awards and 2 times the Guangxi Special Contribution Award for scientific and technological progress; the company has built a national enterprise technology center, postdoctoral research workstation, Guangxi Modern Traditional Chinese Medicine Engineering Technology Research Center, Guangxi Guangxin Traditional Chinese Medicine Research Center, and the 100 billion yuan industrial Guangxi Traditional Chinese Medicine Research and Development Center In 2014, the company was rated as a national technological innovation demonstration enterprise for innovative platforms such as the Guangxi Institute of Traditional Chinese Medicine Industrialization Engineering and the Southwest Military Drug Production Base.

Company Profile

Short Name-A桂林三金
Symbol-A002275
Company NameGuilin Sanjin Pharmaceutical Co., Ltd.
Listing DateJul 10, 2009
Issue Price19.80
Shares Offered46.00M share(s)
FoundedFeb 23, 1994
Listed ExchangeSZ Stock Exchange
Legal Representativexun zou
General Managerxun zou
Secretarychun li
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Securities Representativeye zhu
Legal CounselBeijing Trade Law Firm
Employees1772
Phone0773-5829106
Office AddressNo. 9 Renmin South Road, Lingui District, Guilin, Guangxi Zhuang Autonomous Region
Zip Code541199
Registered AddressNo. 9 Renmin South Road, Lingui District, Guilin, Guangxi Zhuang Autonomous Region
Fax0773-5838652
Emaildsh@sanjin.com.cn
Business License450300000014577
BusinessProduction and operation of tablets, hard capsules, powders, granules, tinctures (for external use) (toxic Chinese medicine pretreatment), tinctures (internal use), pharmaceutical excipients, teas, pills (concentrated pills, honey pills, water pills, big honey pills, small pills, pellets), ointments, syrups, liniments, compounds (oral liquid), alcohol, sprays, traditional Chinese medicine pre-treatment and extraction, granulation; pharmaceutical technology development; import and export trade (excluding specific national regulations). (For projects that require approval according to law, business activities can only be carried out after approval by relevant departments.)

Company Executives

  • Name
  • Position
  • Salary
  • xun zou
  • Chairman,directors,President
  • 2.42M
  • liping fu
  • directors
  • 642.70K
  • jinqian xu
  • directors,Audit Committee Members
  • 632.00K
  • yuangang xie
  • directors,VP,Head of finance
  • 1.33M
  • zhun zou
  • directors,VP
  • 1.19M
  • jingdu lei
  • directors,VP
  • 795.40K
  • liwen he
  • Independent directors
  • 80.00K
  • huanfeng liu
  • Independent directors
  • 40.00K
  • lingxia mo
  • Independent directors
  • 80.00K
  • chun li
  • Board Secretary,VP
  • 728.00K
  • ye zhu
  • Securities affairs representative
  • --
  • zhongyang yang
  • Chairman of the Supervisory Board,auditors
  • 804.80K
  • zhiyu wu
  • auditors
  • 372.00K
  • jinhua xie
  • Head of Internal Audit
  • --
  • ruizhi wang
  • Employee supervisors
  • 421.70K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg